Back to search

University of Leeds

Novel approaches to prevent and treat infections involving staphylococcal biofilms

Abstract

dc:description.abstract

Bacteria can be found as surface adhered, structured colonies that generate an extracellular matrix, known as a biofilm. Biofilms are recalcitrant to antibiotics. Therefore, treatments of biofilm infections are limited, especially in terms of indwelling medical devices. The major causes of biofilm-associated infections on medical implants are S aureus and S. epidermidis. This work sought to identify and characterise compounds with antistaphylococcal antibiofilm activity. Initial studies were performed as a part of the COATIM consortium. The antibacterial and antibiofilm activity of 56 compounds provided by members of the consortium were assessed against bacterial and fungal organisms. The top five (4-45, CIM008405, P1a-PEP1, P2-5 Tocris 2611) compounds were selected for further characterisation based on their antibiofilm activity and toxicity. The MOA of the five compounds were characterised in S. aureus. All five compounds caused membrane perturbation, but Tocris 2611 was the only one to exhibit some prokaryote selectivity. In addition, Tocris 2611 eradicated preformed staphylococcal biofilms by sterilising the biofilm cells and had low resistance potential. The five compounds were then coated on titanium substrates (representing dental/orthopaedic implants) and tested for their ability to prevent biofilm formation in vitro and in vivo against biofilm colonisation in vivo and in vitro. No useful antibiofilm activity was observed. Finally, three chemical libraries of biologically active small molecules were screened for adjuvants of antibiotics ciprofloxacin and rifamipcin against S. aureus biofilms, and rifampicin, fusidic acid or linezolid against planktonic E. coli. No potentiators were determined against S. aureus biofilms at the tested concentrations. However, several synergistic interactions were initially identified against E. coli, but had limited antibacterial activity against multi-drug resistant (MDR) pathogens. Due to the limitations of current antibiofilm strategies and the ability of bacteria to adapt continuously, it is important to consider combining multiple approaches to target biofilms successfully.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lippell, Anna Victoria
Advisor dc:contributor.advisor
  • O'Neill, Alex

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.758277

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Lippell, Anna Victoria. Novel approaches to prevent and treat infections involving staphylococcal biofilms. doctoral thesis, University of Leeds, 2016.